Homepage NewsNews Highlight Ractigen Therapeutics Announces FDA Orphan Drug Designation for RAG-21 for the Treatment of ALS NANTONG and SUZHOU, China, Nov. 19, 2024 — Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated…Jiaqi HuangNovember 19, 2024
